Harmony Biosciences Holdings, Inc.
HRMY · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,611,310 | $1,816,045 | $1,902,117 | $1,964,708 |
| - Cash | $646,999 | $546,050 | $488,998 | $453,001 |
| + Debt | $169,734 | $173,373 | $177,464 | $181,406 |
| Enterprise Value | $1,134,045 | $1,443,368 | $1,590,583 | $1,693,113 |
| Revenue | $239,455 | $200,489 | $184,733 | $201,267 |
| % Growth | 19.4% | 8.5% | -8.2% | – |
| Gross Profit | $179,805 | $162,336 | $152,739 | $146,858 |
| % Margin | 75.1% | 81% | 82.7% | 73% |
| EBITDA | $73,458 | $59,250 | $66,981 | $66,332 |
| % Margin | 30.7% | 29.6% | 36.3% | 33% |
| Net Income | $50,865 | $39,776 | $45,560 | $49,475 |
| % Margin | 21.2% | 19.8% | 24.7% | 24.6% |
| EPS Diluted | 0.87 | 0.68 | 0.78 | 0.85 |
| % Growth | 27.9% | -12.8% | -8.2% | – |
| Operating Cash Flow | $108,734 | $79,327 | $33,987 | $75,562 |
| Capital Expenditures | -$71 | -$4 | -$128 | -$513 |
| Free Cash Flow | $108,663 | $79,323 | $33,859 | $75,049 |